FDA grants approval of Madrigal Pharmaceuticals liver drug
The U.S. Food and Drug Administration (FDA) recently granted accelerated approval for Rezdiffra, a drug for the treatment of adults with noncirrhotic, nonalcoholic steatohepatitis (NASH) with moderate...
Read More